In the sensitivity analysis, self-reported physician-diagnosed T2D (the second criterion) was confirmed with the use of insulin or oral hypoglycemic agents or FPG ≥126 mg/dL in the follow-up exam. The gene discussed is INS; the disease is type 2 diabetes mellitus.